Wednesday, August 28, 2013

Alex Rodriguez is no longer a threat. Somebody tell Selig.

Alex Rodriguez may have used performance enhancing drugs (PED) in recent seasons but they have not enhanced his performance.

Career cumulative through 2009:
BA OBP SLG OPS OPS+
.305 .390 .576 .965 147

BA OBP SLG OPS OPS+
.270 .341 .506 .847 123    2010
.276 .362 .461 .823 119    2011
.272 .353 .430 .783 112    2012
.271 .354 .429 .783 115    2013 through 8/27

For the fourth consecutive season Rodriguez has been consistently good but far from great.  So why the vendetta by Major Baseball League (MBL) commissioner Allen Huber "Bud" Selig?

More to the usual point of the hysteria of the steroid zealots: home run rate.

Career through 2009:


ABHRAB/HR
8,3045830.0702
533300.05632010
373160.04292011
463180.03892012
7030.04292013

Rodriguez is clearly no longer a big time home run threat.  His third HR in 2013 on August 26 was number 650 in his career.  That's ten behind Willie Mays.  Rodriguez has over a month to hit those ten HR and catch Mays.  Who thinks that he can do that?  Ten HR in a month is not that big a deal but as a player ages he loses his youthful abilities.  Rodriguez still has the power but he lacks the knack.

Teammate Derek Jeter, 13 months older, has also dropped precipitously since 2009 when his OPS+ was 125 (121 cumulative career through 2009), although Jeter inexplicably rebounded in 2012 and led the American Conference in plate appearances, at bats and hits.

2010 90
2011 100
2012 114
2013 65

Reasonable milestones that Rodriguez could reach in 2014:
- 2,000 Runs (1,908 currently)
- 2,000 RBI (1,957 currently)
- 3,000 Hits (2,920 currently)
- 661 HR to pass Mays (650 currently)

Wouldn't the MBL be better off with that happening rather than a pointless punishment for offenses that have embarrassed and humiliated Rodriguez and made him an object of ridicule by both the public and many of his fellow players?

Is Alex Rodriguez such a threat to truth, justice and the American way?  Obviously not.  Somebody tell Selig.

No comments: